• Perspectives
    Perspectives

    Our Perspectives are at the forefront of complex or emerging IP challenges, keeping you one step ahead.

    • NFTs : A new asset for your company ?
    • Artificial Intelligence
    • Immunotherapy
    • Unitary patent and UPC
    • Biodiversity
  • Issues
    Issues

    The Issues we focus on target your recurring and strategic IP challenges, through cross-functional support.

    • Reveal my assets value
    • Secure my strategic assets
    • Defend my rights
    • Resolve a dispute through mediation
    • Personal data protection
    • Evaluate and enhance my innovations
    • Generate revenue
    • Align my IP with my business strategy
    • Monitor developments in my markets
    • Conduct a due diligence
    • Finance my R&D
    • Manage my IP budget
    • Build my tailor-made IP checklist
    • Raise my teams' awareness on IP
  • Sectors
    Sectors

    We provide sector-specific support in a number of business areas historically linked to Regimbeau.

    • Aeronautics, Defence and Space
    • Agritech and Foodtech
    • Banking, Management, Finance, Insurance
    • Biotechnology
    • Chemistry
    • Cosmetics
    • Retail, Consumer Goods, Luxury Goods
    • Studies, Engineering and Construction
    • Greentech
    • Software and data
    • Mechanics, Robotics, Electronics
    • Medtech
    • Pharmaceuticals
    • Telecommunications, IOT and media
    • Transport and Logistics
  • Assets
    Assets

    Regardless of the asset to be protected or enhanced, we have the right dedicated team to assist you.

    • Patents
    • Trademarks
    • Designs
    • Domain names
    • Contracts
    • Know-how
    • Copyright
  • Players
    Players

    For each type of company, Regimbeau provides tailor-made support, in line with its realities.

    • Start-ups and scale-ups
    • Technology Transfer Acceleration Companies
    • SMEs and intermediate-sized companies
    • Investors
    • Public Research Establishments
    • Groups and large companies
  • fr
  • en
  • ja
  • About us
    • Convictions
    • Offices
    • News
    • Contact us
    • RSE
  • Team
  • Solutions
  • International
    • EU Clients
    • International Clients
  • Training
  • Careers
Insights Client login
Insights Client login
  • About us
    Back
    Close

    About us

    • Convictions
    • Offices
    • News
    • Contact us
  • Team
  • Perspectives
    Back
    Close

    Perspectives

    Our Perspectives are at the forefront of complex or emerging IP challenges, keeping you one step ahead.

    • Unitary patent and UPC
    • NFTs : A new asset for your company ?
    • Artificial Intelligence
    • Immunotherapy
    • Biodiversity
  • Issues
    Retour
    Fermer

    Issues

    The Issues we focus on target your recurring and strategic IP challenges, through cross-functional support.

    • Reveal my assets value
    • Secure my strategic assets
    • Defend my rights
    • Resolve a dispute through mediation
    • Personal data protection
    • Evaluate and enhance my innovations
    • Generate revenue
    • Align my IP with my business strategy
    • Monitor developments in my markets
    • Conduct a due diligence
    • Finance my R&D
    • Manage my IP budget
    • Build my tailor-made IP checklist
  • Sectors
    Retour
    Fermer

    Sectors

    We provide sector-specific support in a number of business areas historically linked to Regimbeau.

    • Aeronautics, Defence and Space
    • Agritech and Foodtech
    • Banking, Management, Finance, Insurance
    • Biotechnology
    • Chemistry
    • Cosmetics
    • Retail, Consumer Goods, Luxury Goods
    • Studies, Engineering and Construction
    • Greentech
    • Software and data
    • Mechanics, Robotics, Electronics
    • Medtech
    • Pharmaceuticals
    • Telecommunications, IOT and media
    • Transport and Logistics
  • Assets
    Retour
    Fermer

    Assets

    Regardless of the asset to be protected or enhanced, we have the right dedicated team to assist you.

    • Patents
    • Trademarks
    • Designs
    • Domain names
    • Contracts
    • Know-how
    • Copyright
  • Players
    Retour
    Fermer

    Players

    For each type of company, Regimbeau provides tailor-made support, in line with its realities.

    • Groups and large companies
    • SMEs and intermediate-sized companies
    • Start-ups and scale-ups
    • Investors
    • Public Research Establishments
    • Technology Transfer Acceleration Companies
  • Solutions
  • International
    Retour
    Fermer
    • EU Clients
    • International Clients
  • Training
  • Careers
  • fr
  • English
  • ja
  • Home
  • Search Results

27 results found for "Health".

18 Insights 1 professional 1 Expertise 7 News
18 Insights
Load More
Publications - 24 Mar 2023

Processing of personal data by a service provider : beware of the risks of contract cancellation.

By Franck Delamer
#GDPR #Software & Data #Contracts #Data
Publications - 19 Oct 2022

Protection of inventions relating to a dosage or administration regimen in China: possible but only in some cases

By Cécile Puech, Ph.D and Lazarina Choisnel
#Health #Patent
Publications - 17 May 2022

Accelerating examination to obtain a US patent

By Bailey Ziegler, Ph.D
#Patents #PPH
1 professional
Load More

Martine Bloch-Weill

Managing Partner
1 Expertise
Load More
Secteurs

Pharmaceuticals

Regimbeau has been assisting pioneering and innovative companies as well as the best research laboratories for several decades. Our teams have acquired extensive experience in the field of Intellectual Property…

Read more
7 News
Load More
Meetings - 10 Mar 2023

Atlanpole Biotherapies Business Dating – March 6, 2023 – Nantes

Regimbeau took part in the BtoB meetings of Atlanpole Biotherapies, the healthcare innovation hub of the “Grand Ouest” region, in Nantes on Monday March 6th. Caroline Huguet, French Trademark Attorney,…

Par Lazarina Choisnel et Cécile Puech
Webinars - 04 Dec 2020

Medicen Masterclass “AI & Data in Health: How to manage your IP?”

Jean-Robert Callon de Lamarck and Barbara Casadewall will discuss the means of implementing an IP strategy in the development of AI and the use of related data.

Par Lazarina Choisnel et Cécile Puech
Webinars - 26 Nov 2020

France Biotech Webinar “Employee Advocacy, remuneration policies, compensation of inventors in HealthTech”

Barbara Casadewall and Gabrielle Faure-André will discuss inventor compensation practices, the RGPD and the Research Tax Credit in this webinar dedicated to HealthTech HR issues.

Par Lazarina Choisnel et Cécile Puech

Please fill in your email to receive the replay of the webinar

    Please fill in your email to receive the guide

      Created in 1931, Regimbeau’s ambition is to make Intellectual Property a major asset in the development of companies and to give them an advantage in terms of protection, defense and valorization of assets.

      Menu

      • Vision
      • Solutions
      • Offices
      • Training
      • News
      • Careers
      • Team
      • Contact

      Informations

      • Site map
      • Privacy Policy
      • Legal notice
      • Cookie settings

      Follow us

      • Twitter
      • Linkedin
      ISO 9001

      ISO 9001
      2015 for all the activities of
      Intellectual Property consulting activities.

      • ©Regimbeau2023. All rights reserved
      • Agence de communication - Eliott & Markus

      We use cookies to give you the best experience on our site. Manage cookies 

      Regimbeau
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

      Cookie Policy

      More information about our Cookie Policy